United States · FDA National Drug Code directory

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0591-3220_519e2ce9-e4af-4bd7-96fd-8bee4e3b4537
Product NDC
0591-3220
Form
CAPSULE
Composition / generic term
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate
Labeler
Actavis Pharma, Inc.
Marketing category
NDA AUTHORIZED GENERIC
Marketing start / end (source format)
20030918
Source listing expiry
20271231

Source-listed ingredients

  • CODEINE PHOSPHATE — 30 mg/1
  • BUTALBITAL — 50 mg/1
  • CAFFEINE — 40 mg/1
  • ACETAMINOPHEN — 325 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (0591-3220-01) · 0591-3220-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate — United States | Molindra Medicines